The HLH Steering Committee is responsible for charting strategic direction of the HS in their specified areas, including conduct of clinical trials and engagement with the broader group of investigators interested in HLH. 

Current members of the HLH Steering Committee include:

Scott Canna - Chair
Children's Hospital of Philadelphia - Philadelphia, PA USA
Term of Office: 2022 - 2026

Melissa Hines - Co-Chair
St. Jude Children's Research Hospital - Memphis, TN USA
Term of Office: 2023 - 2027

Scott Baker
Fred Hutchinson Cancer Research Center - Seattle, WA USA
Term of Office: 2022-2026

Shanmuganathan Chandrakasan
Emory University, Children's Healthcare of Atlanta - Atlanta, GA USA
Term of Office: 2022 - 2026
  

Randy Cron
University of Alabama at Birmingham - Birmingham, AL USA
Term of Office: 2023 - 2027

Daniel El Fassi
Rigshospitalet Copenhagen University Hospital - Copenhagen, Denmark
Term of Office: 2023 - 2027

 

Kai Lehmberg
University Medical Center Hamburg-Eppendorf - Hamburg, Germany
Term of Office: 2021-2025 

Rafal Machowicz
Medical University of Warsaw - Warsaw, Poland
Term of Office: 2023 - 2027

Despina Moshous
Hopital Necker Enfants Malades - Paris, France
Term of Office: 2024 - 2028

Zhao Wang
Beijing Friendship Hospital, Capital Medical University - Beijing, China
Term of Office: 2023 - 2027

Takahiro Yasumi
Kyoto University Graduate School of Medicine - Kyoto, Japan
Term of Office: 2024 - 2028

 

 
 
 
332 N Broadway | Pitman, NJ 08071 USA
+1 (856) 589-6606 | secretariat@histiocytesociety.org
2026 Histiocyte Society.
All Rights Reserved.